Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT06945172
NA

Comparison of Prostate Cancer-related Quality of Life in Sexually Active Men With Favourable Intermediate-risk Localised Prostate Cancer Treated With Total Prostatectomy or Focal HIFU

Sponsor: GCS Ramsay Santé pour l'Enseignement et la Recherche

View on ClinicalTrials.gov

Summary

The goal of this trial is to assess the impact of focal HIFU therapy on quality of life in patients with favourable intermediate-risk localised prostate cancer. The main question it aims to answer is: What is the prostate cancer-related quality of life in patients with favourable intermediate-risk localised cancer treated by total prostatectomy or focal HIFU ? Researchers will compare patients with favourable intermediate-risk localised cancer treated by total prostatectomy to patients with favourable intermediate-risk localised cancer treated by focal HIFU to see their quality of life. Participants will answer EPIC-CP questionnaire 6 months, 12 months and 24 months after treatment

Key Details

Gender

MALE

Age Range

40 Years - 75 Years

Study Type

INTERVENTIONAL

Enrollment

102

Start Date

2025-10-01

Completion Date

2028-12-31

Last Updated

2025-09-29

Healthy Volunteers

No

Conditions

Interventions

PROCEDURE

Total prostatectomy

Total prostatectomy is a surgical procedure performed to treat prostate cancer.

PROCEDURE

Focal HIFU

Focal HIFU treatment is an innovative technique that consists of destroying prostate tumour cells using high-intensity ultrasound focused exclusively on the affected area of the gland.

Locations (1)

Clinique La Croix du Sud

Quint-Fonsegrives, France